Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03633331
Brief Title: Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer

First Submitted : August 7, 2018
First Submitted that Met QC Criteria : August 15, 2018
First Posted : August 16, 2018

Last Update Submitted that Met QC Criteria : May 14, 2019
Last Update Posted : May 16, 2019